Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.

Dr Stephen Simpson and Pierre Espinasse
Dr Stephen Simpson (L) has taken on the role of CEO from Pierre Espinasse (R)

Stephen has taken over the leadership of the Trust from Pierre Espinasse who managed operations at the charity since 2011. The Trust has evolved considerably under Pierre's expert guidance, most notably through its support of the Kennedy Institute's relocation from Imperial College London to its current site at the heart of the University of Oxford's Old Road Campus.

Pierre has also overseen significant funding and support initiatives at the Kennedy Institute including a pledge of £20M over five years to support pioneering research into chronic inflammatory disease, and funding to establish the Career Development Programme, enabling early career researchers to take the first step in running their own lab. The Kennedy Institute also benefits from some of the Trust's key external funding initiatives, spearheaded by Pierre, including the £2.5M Senior Research Fellowship programme launched in 2017 and the MB PhD scheme which will provide funding for 75 students over 7 years across the universities of Manchester, Birmingham, Oxford, Glasgow and Edinburgh.

Professor Dame Fiona Powrie, Director of the Kennedy Institute, added "Pierre has provided vital support to the Kennedy Institute for more than a decade. We wish him all the best for the future, and we look forward to continuing our close relationship with the Kennedy Trust under the expert leadership of Stephen Simpson."

Stephen joins the Trust with a background in medical research and in life sciences research funding. Most recently, Stephen was Director of Research at Versus Arthritis, where he led teams in the development and implementation of research, including new areas of research translation and partnership funding. During his time at the charity, Stephen championed the development of musculoskeletal research through the creation of new funding initiatives and the promotion of pain research and patient involvement.

See more on the Kennedy Trust website

Similar stories

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Professor Chris Buckley joins the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.

The Kennedy Institute scoops sustainability award

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

The Kennedy Institute Student Symposium returns for its 5th year

A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.